Skip to main content

Prevoznik Michael E's Form 4 filing

Quest Diagnostics Inc (DGX) · filed Sep 25, 2025

Accession no.
0001222679-25-000004
Filed
Sep 25, 2025
Trade date
Sep 23-24, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $5.33M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Prevoznik Michael ECIK 0001222679Officer (SVP & General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 23, 2025Common StockMOption exerciseAcquired+28,288$103.57+$2,929,788.1666,405Direct
Sep 23, 2025Common StockSSaleDisposed−28,288$187.12−$5,293,250.5638,117Direct
Sep 24, 2025Common StockMOption exerciseAcquired+175$103.57+$18,124.7538,292Direct
Sep 24, 2025Common StockSSaleDisposed−175$187.02−$32,728.538,117Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 23, 2025Common StockMOption exerciseDisposed−28,288$103.57−$2,929,788.16402Direct
Sep 24, 2025Common StockMOption exerciseDisposed−175$103.57−$18,124.75227Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)